Follow Us
https://www.thebody.com/category/financial-issues-hiv/tag/news

The Latest

Investigation of Humana's Discriminatory HIV Drug Pricing Ends With a Fine and a Promise -- But Practice Continues With HCV Meds Img

Investigation of Humana's Discriminatory HIV Drug Pricing Ends With a Fine and a Promise -- But Practice Continues With HCV Meds

Florida's insurance commissioner will impose a $500,000 fine on Humana following an investigation into allegations that the health insurance company price gouged prescription drugs for people living with HIV.

How Shkreli's Turing Pharmaceuticals Sought to Placate the HIV Community About Its Drug Price Hike Img

How Shkreli's Turing Pharmaceuticals Sought to Placate the HIV Community About Its Drug Price Hike

When Martin Shkreli's Turing Pharmaceuticals planned to make billions through a drug price hike, it knew HIV activists could present an obstacle. Here's how it planned to neutralize the threat to its profiteering.

New Analysis Finds Marketplace Plans With Lowest Premiums Are Often Not the Most Cost-Effective Option for People With HIV Img

New Analysis Finds Marketplace Plans With Lowest Premiums Are Often Not the Most Cost-Effective Option for People With HIV

People with HIV can find lower cost plans by conducting a more comprehensive cost assessment that includes other factors such as deductibles, drug costs, and out-of-pocket maximums.

Worlds Apart: Vast Disparities in Treatment Separate Americans With HIV Img

Worlds Apart: Vast Disparities in Treatment Separate Americans With HIV

Despite significant medical advances in treating HIV, very different realities divide the 1.2 million Americans living with HIV. Many -- primarily people of color -- are left behind because of life circumstances.

Martin Shkreli Is a Grinch, but His Arrest Won't Drop HIV Drug Prices or Expand Access Img

Martin Shkreli Is a Grinch, but His Arrest Won't Drop HIV Drug Prices or Expand Access

Shkreli's arrest has everything to do with how the U.S. has laws that watch investors' backs, contends JD Davids. But we don't have the laws we need on drug pricing and access, she argues, and that lets a thousand Grinches grin.

Help Choosing a Covered California Plan for HIV, HCV or PrEP Coverage Img

Help Choosing a Covered California Plan for HIV, HCV or PrEP Coverage

Before Jan. 31, people living in California can register for affordable health insurance through Covered California, the state's insurance exchange. For those living with HIV or on PrEP, there are some key things to keep in mind when choosing a plan....

If Half a Billion Dollars for HIV Services and Treatment Disappears, Who Pays the Price? Img

If Half a Billion Dollars for HIV Services and Treatment Disappears, Who Pays the Price?

The 340B program was meant to provide an income stream for cash-strapped HIV agencies and state programs that provide HIV drugs. But a proposed rule change could gut the payment stream that has kept agencies afloat and people on meds, leading to long...

Why Are HIV Meds So Expensive, and What Can We Do About It? Img

Why Are HIV Meds So Expensive, and What Can We Do About It?

Why do Americans and their insurers pay more for some drugs and less for others? And who decides what a fair price for a drug should be, and how can manufacturers and health plans be compelled to improve access and affordability?

HIV Activists Storm Turing Pharmaceuticals Lobby and Demand Fair Pricing Img

HIV Activists Storm Turing Pharmaceuticals Lobby and Demand Fair Pricing

"We wanted to call attention to the fact that this isn't just about one scummy hedge fund guy, but a whole bunch of them," explained Michael Kink of HedgeClippers. "Twenty of the 25 drugs with the fastest-rising prices over the past two years are lin...

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug Img

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug

The Fair Pricing Coalition says that patients, insurers and public programs shouldn't have to pay higher costs for a next-generation HIV treatment could make combination therapy less toxic.